DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
出版年份 2020 全文链接
标题
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
作者
关键词
-
出版物
Cells
Volume 9, Issue 3, Pages 624
出版商
MDPI AG
发表日期
2020-03-06
DOI
10.3390/cells9030624
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
- (2019) Maria Panagopoulou et al. ONCOGENE
- Early Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.
- (2019) Raymond U. Osarogiagbon et al. Journal of Thoracic Oncology
- Liquid Biopsy: General Concepts
- (2019) Geoffroy Poulet et al. ACTA CYTOLOGICA
- Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies
- (2019) Vera Constâncio et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies
- (2019) Louise Katrine Larsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The mSHOX2 is capable of assessing the therapeutic effect and predicting the prognosis of stage IV lung cancer
- (2019) Xiumei Peng et al. Journal of Thoracic Disease
- Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
- (2019) Jesús Beltrán-García et al. Frontiers in Genetics
- High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
- (2019) Alessio Amatu et al. Frontiers in Oncology
- Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
- (2019) Guodong Zhao et al. Cancer Medicine
- Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
- (2019) Nunes et al. Journal of Clinical Medicine
- Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
- (2019) Sarah Østrup Jensen et al. Clinical Epigenetics
- Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel
- (2019) Vera Constâncio et al. Clinical Epigenetics
- Evolution in Prostate Cancer Staging
- (2018) Samson W. Fine ADVANCES IN ANATOMIC PATHOLOGY
- Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
- (2018) L Liu et al. ANNALS OF ONCOLOGY
- Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
- (2018) Julia Bergheim et al. BRITISH JOURNAL OF CANCER
- Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients
- (2018) Dandan Li et al. CLINICA CHIMICA ACTA
- Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients
- (2018) Beatriz E. Sánchez et al. Clinical Genitourinary Cancer
- BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients
- (2018) Parisa Rokni et al. Genes & Genomics
- Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival
- (2018) David H. Murray et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The more potential performance of nidogen 2 methylation by tissue or plasma DNA over brichoalveolar lavage DNA in diagnosis of nonsmall cell lung cancer
- (2018) Jiajin Qin et al. Journal of Cancer Research and Therapeutics
- Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
- (2018) Christa Haldrup et al. Molecular Oncology
- CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data
- (2018) Wenyuan Li et al. NUCLEIC ACIDS RESEARCH
- Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
- (2018) Rianne J. Hendriks et al. PROSTATE
- Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias
- (2018) Yutaka Suehiro et al. Oncotarget
- Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
- (2018) Erin L. Symonds et al. Clinical Epigenetics
- ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
- (2018) Martin H.D. Neumann et al. Computational and Structural Biotechnology Journal
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
- (2018) José Marrugo-Ramírez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women
- (2018) Sandra Nunes et al. Cancers
- Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial
- (2018) Kate L. Mahon et al. EUROPEAN UROLOGY
- Clinical epigenetics: seizing opportunities for translation
- (2018) María Berdasco et al. NATURE REVIEWS GENETICS
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
- (2018) Joshua Moss et al. Nature Communications
- DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA
- (2018) Zhiping Yang et al. Advances in Clinical and Experimental Medicine
- A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
- (2018) Sofia Salta et al. Journal of Clinical Medicine
- Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples
- (2017) Barbara Kinga Barták et al. Epigenetics
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
- (2017) Andreas Herbst et al. INTERNATIONAL JOURNAL OF CANCER
- Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- European position statement on lung cancer screening
- (2017) Matthijs Oudkerk et al. LANCET ONCOLOGY
- Liquid biopsy: a step forward towards precision medicine in urologic malignancies
- (2017) Ashley Di Meo et al. Molecular Cancer
- Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
- (2017) Yvette N. Lamb et al. Molecular Diagnosis & Therapy
- Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
- (2017) Simon Ladefoged Rasmussen et al. PLoS One
- DNA methylation markers for diagnosis and prognosis of common cancers
- (2017) Xiaoke Hao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colorectal cancer screening: An updated review of the available options
- (2017) Iyad A Issa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method
- (2017) Nayebali Rezvani et al. Oncology Letters
- Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients
- (2017) Mariana Brait et al. Oncotarget
- The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
- (2017) Lele Song et al. Scientific Reports
- Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer
- (2017) Ying-Li Lin et al. MEDICAL SCIENCE MONITOR
- Circulating Tumor DNA as Biomarkers for Cancer Detection
- (2017) Xiao Han et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
- (2016) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Grading of prostatic adenocarcinoma: current state and prognostic implications
- (2016) Jennifer Gordetsky et al. Diagnostic Pathology
- WOMEN IN CANCER THEMATIC REVIEW: Diverse functions of DNA methylation: implications for prostate cancer and beyond
- (2016) Thomas J Sweet et al. ENDOCRINE-RELATED CANCER
- Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review
- (2016) Roderick C.N. van den Bergh et al. EUROPEAN UROLOGY
- The impact of next-generation sequencing on the DNA methylation–based translational cancer research
- (2016) Javier Soto et al. Translational Research
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
- (2016) Feifei Cheng et al. Oncotarget
- Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
- (2016) Ming Shan et al. Oncotarget
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
- (2016) Qiu-Kui Deng et al. MEDICAL SCIENCE MONITOR
- A cross-sectional study comparing a blood test for methylatedBCAT1 and IKZF1tumor-derived DNA with CEA for detection of recurrent colorectal cancer
- (2016) Graeme P. Young et al. Cancer Medicine
- Colorectal cancer development and advances in screening
- (2016) Vanessa Balchen et al. Clinical Interventions in Aging
- Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
- (2016) Susan Mitchell et al. Genes
- A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
- (2016) Erin L Symonds et al. Clinical and Translational Gastroenterology
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
- (2015) Susanne K. Pedersen et al. BMC CANCER
- Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
- (2015) I M Reis et al. BRITISH JOURNAL OF CANCER
- Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
- (2015) T. Powrózek et al. Clinical & Translational Oncology
- Comparing sensitivity and specificity of screening mammography in the United States and Denmark
- (2015) Katja Kemp Jacobsen et al. INTERNATIONAL JOURNAL OF CANCER
- Aberrant methylation ofAPCandRARβ2genes in breast cancer patients
- (2015) Menha Swellam et al. IUBMB LIFE
- Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer
- (2015) Deyuan Fu et al. MEDICINE
- Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas
- (2015) Xie Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnostic and prognostic epigenetic biomarkers in cancer
- (2015) Pedro Costa-Pinheiro et al. Epigenomics
- Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
- (2015) Hong Wang et al. Clinical Epigenetics
- Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy
- (2015) Ying-Li Lin et al. MEDICAL SCIENCE MONITOR
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
- (2015) Susanne K. Pedersen et al. PLoS One
- Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
- (2014) Andreas Adler et al. BMC GASTROENTEROLOGY
- Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
- (2014) I Balgkouranidou et al. BRITISH JOURNAL OF CANCER
- Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer
- (2014) CheeKian Tham et al. CANCER
- Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
- (2014) V. Melotte et al. Cancer Prevention Research
- Screening for lung cancer
- (2014) Helmut Prosch et al. CURRENT OPINION IN ONCOLOGY
- CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia
- (2014) Susanne K Pedersen et al. Epigenetics
- Plasma methylated septin 9: a colorectal cancer screening marker
- (2014) Béla Molnár et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer
- (2014) Li Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
- (2014) Tomasz Powrózek et al. MEDICAL ONCOLOGY
- Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
- (2014) Kinga Tóth et al. PLoS One
- Common features of chromatin in aging and cancer: cause or coincidence?
- (2014) Linda Zane et al. TRENDS IN CELL BIOLOGY
- Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
- (2014) Kun Nie et al. TUMOR BIOLOGY
- Aberrant promoter methylation ofPPP1R3CandEFHD1in plasma of colorectal cancer patients
- (2014) Kiyoko Takane et al. Cancer Medicine
- Serum methylation levels ofTAC1. SEPT9andEYA4as diagnostic markers for early colorectal cancers: a pilot study
- (2013) Yanqun Liu et al. BIOMARKERS
- Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer
- (2013) Jean-Pierre Roperch et al. BMC CANCER
- Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer
- (2013) L. Li et al. Clinical & Translational Oncology
- Prostate Cancer Molecular Detection in Plasma Samples by Glutathione S-Transferase P1 (GSTP1) Methylation Analysis
- (2013) Raluca Dumache et al. Clinical Laboratory
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer
- (2013) TaeJeong Oh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
- (2013) K. C. A. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets
- (2013) Robert Daber et al. Cancer Genetics
- Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis
- (2012) Mercedes Zurita et al. BMC CANCER
- CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
- (2012) Maria Chimonidou et al. CLINICAL BIOCHEMISTRY
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- Current and emerging treatments in the management of castration-resistant prostate cancer
- (2012) David Shapiro et al. Expert Review of Anticancer Therapy
- Epigenetic biomarkers in colorectal cancer diagnostics
- (2012) James B Rawson et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer
- (2012) Seung-Chul Pack et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers
- (2012) Michael J. Duffy MEDICAL PRINCIPLES AND PRACTICE
- Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer
- (2012) Su Man Lee et al. MOLECULES AND CELLS
- Risk stratification in prostate cancer screening
- (2012) Monique J. Roobol et al. Nature Reviews Urology
- Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer
- (2011) Andreas Herbst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
- (2011) Georg Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
- (2011) Noriaki Yamamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
- (2011) T Wu et al. BRITISH JOURNAL OF CANCER
- Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer
- (2011) Youwei Zhang et al. CANCER LETTERS
- Detection of TFPI2 methylation in the serum of colorectal cancer patients
- (2011) Kenji Hibi et al. CANCER LETTERS
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients
- (2011) Ping-ping Wu et al. Chinese Journal of Cancer Research
- An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA
- (2011) S. Begum et al. CLINICAL CANCER RESEARCH
- The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia
- (2011) David A. Ahlquist et al. Clinical Gastroenterology and Hepatology
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- (2011) Carmen Jerónimo et al. EUROPEAN UROLOGY
- DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps
- (2011) Elisa Cassinotti et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer
- (2011) Chanida Vinayanuwattikun et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Screening for Prostate Cancer
- (2011) Richard M. Hoffman NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer
- (2011) Ramin Radpour et al. PLoS One
- Quantitative detection of methylated ESR1 and 14-3-3-σ gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy
- (2010) Joaquina Martínez-Galán et al. CANCER BIOLOGY & THERAPY
- Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer
- (2010) Qiong He et al. CANCER GENETICS AND CYTOGENETICS
- Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA
- (2010) Inas A. Ahmed et al. CANCER GENETICS AND CYTOGENETICS
- Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR
- (2010) K. L. Ostrow et al. CLINICAL CANCER RESEARCH
- Frequent Epigenetic Inactivation of Deleted in Lung and Esophageal Cancer 1 Gene by Promoter Methylation in Non–Small-Cell Lung Cancer
- (2010) Youwei Zhang et al. Clinical Lung Cancer
- Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women
- (2010) Jo-Heon Kim et al. GYNECOLOGIC ONCOLOGY
- First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
- (2010) Fernanda Salazar et al. LUNG CANCER
- Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer
- (2010) Y. Zhang et al. NEOPLASMA
- From discovery to the clinic: the novel DNA methylation biomarkermSEPT9 for the detection of colorectal cancer in blood
- (2010) Shannon R Payne Epigenomics
- The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
- (2009) I Van der Auwera et al. BRITISH JOURNAL OF CANCER
- Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry
- (2009) H. Yazici et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer
- (2009) Youwei Zhang et al. CANCER SCIENCE
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
- (2009) B. B. Lee et al. CLINICAL CANCER RESEARCH
- Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
- (2009) E. Sunami et al. CLINICAL CHEMISTRY
- Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence
- (2009) Andreas Herbst et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Sensitive digital quantification of DNA methylation in clinical samples
- (2009) Meng Li et al. NATURE BIOTECHNOLOGY
- DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection
- (2009) Shannon R. Payne et al. PROSTATE
- CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate Cancer
- (2008) Patrick J. Bastian et al. JOURNAL OF UROLOGY
- Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients
- (2008) Yu-Cai Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started